B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation

• Xiaojie Wang,

  Affiliation Department of Surgery, University of British Columbia, Vancouver, Canada

  ⨯
• Jianqiang Hao,

  Affiliation Department of Surgery, University of British Columbia, Vancouver, Canada

  ⨯
• Daniel L. Metzger,

  Affiliation Department of Pediatrics, University of British Columbia, Vancouver, Canada

  ⨯
• Ziliang Ao,

  Affiliation Department of Surgery, University of British Columbia, Vancouver, Canada

  ⨯
• Lieping Chen,

  Affiliation Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America

  ⨯
• Dawei Ou,

  Affiliation Department of Surgery, University of British Columbia, Vancouver, Canada

  ⨯
• C. Bruce Verchere,

  Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada

  ⨯
• Alice Mui,

  Affiliation Department of Surgery, University of British Columbia, Vancouver, Canada

  ⨯
• Garth L. Warnock

  * E-mail: Garth.Warnock@vch.ca

  Affiliation Department of Surgery, University of British Columbia, Vancouver, Canada

  ⨯